| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d0509999848c1a507744004399d3516f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d40285e27f4ed83b8728b0d477404958 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4738
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-22 |
| filingDate |
2019-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5156b6661170802c3ac2bf6209c92a8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a27e62fe45bf59a4c2563b20e3e7a5cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1796ff5a4e23e98028a7a0e327083042 |
| publicationDate |
2021-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-112770755-A |
| titleOfInvention |
Compositions, syntheses, preparations and uses of analogs derived from position 7 and 9 of platform drug FL118 for treating human diseases |
| abstract |
Described herein are chemical syntheses, compositions, formulations, functions, methods and uses of platform drug FL118 position 7 and/or position 9 derived analogs for treating cancer or other human diseases. The compound derived from the chemical modification of the platform drug FL118 can be used alone or in combination with other anticancer agents to prevent, eliminate or reverse the cancer phenotype. The present invention aims to achieve a unique personalized cancer treatment (personalized precise medicine) by applying a series of structurally related platform drug FL118 derived various individual analogues. The platform drug FL118 analog targets a variety of human disease-associated proteins and their signaling pathways in cancer cells. |
| priorityDate |
2018-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |